Ondansetron

Product NDC
65862-391
11-digit product format
658620391
Labeler code
65862
Product ID
65862-391_aab5d8ee-a492-4deb-b240-62b1b0eb0aa8
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Ondansetron
Dosage form
TABLET, ORALLY DISINTEGRATING
Route
ORAL
Labeler
Aurobindo Pharma Limited
Application
ANDA090469
Marketing category
ANDA
Marketing start
2010-04-12
Substance
ONDANSETRON
Active strength
8 mg/1
Pharmacologic classes
Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A090469-001ONDANSETRONONDANSETRON4MGTABLET, ORALLY DISINTEGRATING / ORALAB2010-04-12
A090469-002ONDANSETRONONDANSETRON8MGTABLET, ORALLY DISINTEGRATING / ORALABRS2010-04-12

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 2 matching rows.

Application-product, TE code table
Application-productTE code
A090469-001AB
A090469-002AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 86 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-09-14 22:38:342026-08A090469-001ONDANSETRON4MGTABLET, ORALLY DISINTEGRATING / ORALAB2010-04-1284e616aacf4f…
2026-09-14 22:38:342026-08A090469-002ONDANSETRON8MGTABLET, ORALLY DISINTEGRATING / ORALABRS2010-04-1284e616aacf4f…
2026-08-18 06:07:402026-07A090469-001ONDANSETRON4MGTABLET, ORALLY DISINTEGRATING / ORALAB2010-04-12caaa826d4ba7…
2026-08-18 06:07:402026-07A090469-002ONDANSETRON8MGTABLET, ORALLY DISINTEGRATING / ORALABRS2010-04-12caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A090469-001ONDANSETRON4MGTABLET, ORALLY DISINTEGRATING / ORALAB2010-04-12011fe1cb6892…
2026-02-19 14:30 UTC2026-02A090469-002ONDANSETRON8MGTABLET, ORALLY DISINTEGRATING / ORALABRS2010-04-12011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A090469-001ONDANSETRON4MGTABLET, ORALLY DISINTEGRATING / ORALAB2010-04-1231067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A090469-002ONDANSETRON8MGTABLET, ORALLY DISINTEGRATING / ORALABRS2010-04-1231067a03dcf5…
2025-08-23 18:47 UTC2025-08A090469-001ONDANSETRON4MGTABLET, ORALLY DISINTEGRATING / ORALAB2010-04-126a471c1ec25d…
2025-08-23 18:47 UTC2025-08A090469-002ONDANSETRON8MGTABLET, ORALLY DISINTEGRATING / ORALABRS2010-04-126a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A090469-001ONDANSETRON4MGTABLET, ORALLY DISINTEGRATING / ORALAB2010-04-12fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A090469-002ONDANSETRON8MGTABLET, ORALLY DISINTEGRATING / ORALABRS2010-04-12fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A090469-001ONDANSETRON4MGTABLET, ORALLY DISINTEGRATING / ORALAB2010-04-12b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A090469-002ONDANSETRON8MGTABLET, ORALLY DISINTEGRATING / ORALABRS2010-04-12b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A090469-001ONDANSETRON4MGTABLET, ORALLY DISINTEGRATING / ORALAB2010-04-1203ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A090469-002ONDANSETRON8MGTABLET, ORALLY DISINTEGRATING / ORALABRS2010-04-1203ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A090469-001ONDANSETRON4MGTABLET, ORALLY DISINTEGRATING / ORALAB2010-04-122680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A090469-002ONDANSETRON8MGTABLET, ORALLY DISINTEGRATING / ORALABRS2010-04-122680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A090469-001ONDANSETRON4MGTABLET, ORALLY DISINTEGRATING / ORALAB2010-04-125bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A090469-002ONDANSETRON8MGTABLET, ORALLY DISINTEGRATING / ORALABRS2010-04-125bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A090469-001ONDANSETRON4MGTABLET, ORALLY DISINTEGRATING / ORALAB2010-04-12d8e5a09893c0…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A090469-002ONDANSETRON8MGTABLET, ORALLY DISINTEGRATING / ORALABRS2010-04-12d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A090469-001ONDANSETRON4MGTABLET, ORALLY DISINTEGRATING / ORALAB2010-04-12d06236e962d9…
2024-10-29 15:01 UTC2024-10A090469-002ONDANSETRON8MGTABLET, ORALLY DISINTEGRATING / ORALABRS2010-04-12d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A090469-001ONDANSETRON4MGTABLET, ORALLY DISINTEGRATING / ORALAB2010-04-1279d66fd596c7…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A090469-002ONDANSETRON8MGTABLET, ORALLY DISINTEGRATING / ORALABRS2010-04-1279d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A090469-001ONDANSETRON4MGTABLET, ORALLY DISINTEGRATING / ORALAB2010-04-12301d65b070ca…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A090469-002ONDANSETRON8MGTABLET, ORALLY DISINTEGRATING / ORALABRS2010-04-12301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A090469-001ONDANSETRON4MGTABLET, ORALLY DISINTEGRATING / ORALAB2010-04-121e350fbaab3a…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A090469-002ONDANSETRON8MGTABLET, ORALLY DISINTEGRATING / ORALABRS2010-04-121e350fbaab3a…
2024-05-31 18:47 UTC2024-05A090469-001ONDANSETRON4MGTABLET, ORALLY DISINTEGRATING / ORALAB2010-04-128072bd15b7f6…
2024-05-31 18:47 UTC2024-05A090469-002ONDANSETRON8MGTABLET, ORALLY DISINTEGRATING / ORALABRS2010-04-128072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A090469-001ONDANSETRON4MGTABLET, ORALLY DISINTEGRATING / ORALAB2010-04-125c6f7cd8ea54…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A090469-002ONDANSETRON8MGTABLET, ORALLY DISINTEGRATING / ORALABRS2010-04-125c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04A090469-001ONDANSETRON4MGTABLET, ORALLY DISINTEGRATING / ORALAB2010-04-125d02ea3f76ae…
2022-04-08 23:34 UTC2022-04A090469-002ONDANSETRON8MGTABLET, ORALLY DISINTEGRATING / ORALABRS2010-04-125d02ea3f76ae…
2022-04-04 05:41 UTC2022-04A090469-001ONDANSETRON4MGTABLET, ORALLY DISINTEGRATING / ORALAB2010-04-124b0b4de00fa7…
2022-04-04 05:41 UTC2022-04A090469-002ONDANSETRON8MGTABLET, ORALLY DISINTEGRATING / ORALABRS2010-04-124b0b4de00fa7…
2019-12-13 00:20 UTC2019-12A090469-001ONDANSETRON4MGTABLET, ORALLY DISINTEGRATING / ORALAB2010-04-1274a2ff9319b5…
2019-12-13 00:20 UTC2019-12A090469-002ONDANSETRON8MGTABLET, ORALLY DISINTEGRATING / ORALAB2010-04-1274a2ff9319b5…

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 3 · 86 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-09-14 22:38:342026-08A090469-001AB184e616aacf4f…
2026-09-14 22:38:342026-08A090469-002AB184e616aacf4f…
2026-08-18 06:07:402026-07A090469-001AB1caaa826d4ba7…
2026-08-18 06:07:402026-07A090469-002AB1caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A090469-001AB1011fe1cb6892…
2026-02-19 14:30 UTC2026-02A090469-002AB1011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A090469-001AB131067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A090469-002AB131067a03dcf5…
2025-08-23 18:47 UTC2025-08A090469-001AB16a471c1ec25d…
2025-08-23 18:47 UTC2025-08A090469-002AB16a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A090469-001AB1fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A090469-002AB1fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A090469-001AB1b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A090469-002AB1b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A090469-001AB103ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A090469-002AB103ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A090469-001AB12680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A090469-002AB12680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A090469-001AB15bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A090469-002AB15bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A090469-001AB1d8e5a09893c0…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A090469-002AB1d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A090469-001AB1d06236e962d9…
2024-10-29 15:01 UTC2024-10A090469-002AB1d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A090469-001AB179d66fd596c7…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A090469-002AB179d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A090469-001AB1301d65b070ca…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A090469-002AB1301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A090469-001AB11e350fbaab3a…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A090469-002AB11e350fbaab3a…
2024-05-31 18:47 UTC2024-05A090469-001AB18072bd15b7f6…
2024-05-31 18:47 UTC2024-05A090469-002AB18072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A090469-001AB15c6f7cd8ea54…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A090469-002AB15c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04A090469-001AB15d02ea3f76ae…
2022-04-08 23:34 UTC2022-04A090469-002AB15d02ea3f76ae…
2022-04-04 05:41 UTC2022-04A090469-001AB14b0b4de00fa7…
2022-04-04 05:41 UTC2022-04A090469-002AB14b0b4de00fa7…
2019-12-13 00:20 UTC2019-12A090469-001AB174a2ff9319b5…
2019-12-13 00:20 UTC2019-12A090469-002AB174a2ff9319b5…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Additional Listing Data#

Finished product
Yes
Brand name base
Ondansetron
Listing expiration
2026-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
ONDANSETRON8 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
4AF302ESOSInternal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 2 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
104894Internal RxNorm lookup
312087Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
cab63f24-8728-4927-aba5-53e8d2e44cdbAvailable on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
d9bd4853-037c-6968-f4d4-9bb9a0efd1eaProduct name220250722
a62a50ac-1535-4461-9768-8ae703e2e9fbProduct name120210525
32e23bc9-ce14-4555-bb6d-bcb654d7d296Product name120201015
e459f50a-1553-4aab-b6bd-1e5f0c211c49Product name120201015
48747306-602a-42cc-957b-5b0c69158eeeProduct name120180604
909480fe-0d18-c1c1-a658-0bd9a7131822Product name520170829
9514609b-a2a9-f8ec-6ba6-3f8e5ee89877Product name120140508
bc07ef78-e82d-0c19-31f4-31f263780582Product name120140508
db5ebcdb-b6ae-21cd-4dc5-76cd84b5578bProduct name120140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
65862-391-01Ondansetron10 in 1 BLISTER PACKTABLET, ORALLY DISINTEGRATING1020
65862-391-01Ondansetron1 in 1 CARTONTABLET, ORALLY DISINTEGRATING120
65862-391-02Ondansetron100 in 1 BOTTLETABLET, ORALLY DISINTEGRATING10020
65862-391-05Ondansetron500 in 1 BOTTLETABLET, ORALLY DISINTEGRATING50020
65862-391-10Ondansetron3 in 1 CARTONTABLET, ORALLY DISINTEGRATING320
65862-391-10Ondansetron10 in 1 BLISTER PACKTABLET, ORALLY DISINTEGRATING1020
65862-391-30Ondansetron30 in 1 BOTTLETABLET, ORALLY DISINTEGRATING3020
65862-391-66Ondansetron6000 in 1 BOTTLETABLET, ORALLY DISINTEGRATING600020

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
65862-391-10EA - Each65862-391148fcc64-db16-4186-b972-6af5daf7db4212012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
ONDANSETRONACTIVE INGREDIENT4AF302ESOSONDANSETRON TABLET, ORALLY DISINTEGRATING [AUROBINDO PHARMA LIMITED]9
ONDANSETRONACTIVE MOIETY4AF302ESOSONDANSETRON TABLET, ORALLY DISINTEGRATING [AUROBINDO PHARMA LIMITED]9
ASPARTAMEINACTIVE INGREDIENTZ0H242BBR1ONDANSETRON TABLET, ORALLY DISINTEGRATING [AUROBINDO PHARMA LIMITED]9
CELLULOSE, MICROCRYSTALLINEINACTIVE INGREDIENTOP1R32D61UONDANSETRON TABLET, ORALLY DISINTEGRATING [AUROBINDO PHARMA LIMITED]9
CROSPOVIDONEINACTIVE INGREDIENT68401960MKONDANSETRON TABLET, ORALLY DISINTEGRATING [AUROBINDO PHARMA LIMITED]9
LACTOSE MONOHYDRATEINACTIVE INGREDIENTEWQ57Q8I5XONDANSETRON TABLET, ORALLY DISINTEGRATING [AUROBINDO PHARMA LIMITED]9
MAGNESIUM STEARATEINACTIVE INGREDIENT70097M6I30ONDANSETRON TABLET, ORALLY DISINTEGRATING [AUROBINDO PHARMA LIMITED]9
MANNITOLINACTIVE INGREDIENT3OWL53L36AONDANSETRON TABLET, ORALLY DISINTEGRATING [AUROBINDO PHARMA LIMITED]9
SILICON DIOXIDEINACTIVE INGREDIENTETJ7Z6XBU4ONDANSETRON TABLET, ORALLY DISINTEGRATING [AUROBINDO PHARMA LIMITED]9
ONDANSETRONACTIVE INGREDIENT4AF302ESOSONDANSETRON TABLET, ORALLY DISINTEGRATING [DIRECT RX]2
ONDANSETRONACTIVE INGREDIENT4AF302ESOSONDANSETRON TABLET, ORALLY DISINTEGRATING [PREFERRED PHARMACEUTICALS, INC.]2
ONDANSETRONACTIVE INGREDIENT4AF302ESOSONDANSETRON TABLET, ORALLY DISINTEGRATING [RXCHANGE CO.]2
ONDANSETRONACTIVE MOIETY4AF302ESOSONDANSETRON TABLET, ORALLY DISINTEGRATING [RXCHANGE CO.]2
ONDANSETRONACTIVE MOIETY4AF302ESOSONDANSETRON TABLET, ORALLY DISINTEGRATING [PREFERRED PHARMACEUTICALS, INC.]2
ONDANSETRONACTIVE MOIETY4AF302ESOSONDANSETRON TABLET, ORALLY DISINTEGRATING [DIRECT RX]2
ASPARTAMEINACTIVE INGREDIENTZ0H242BBR1ONDANSETRON TABLET, ORALLY DISINTEGRATING [RXCHANGE CO.]2
ASPARTAMEINACTIVE INGREDIENTZ0H242BBR1ONDANSETRON TABLET, ORALLY DISINTEGRATING [PREFERRED PHARMACEUTICALS, INC.]2
ASPARTAMEINACTIVE INGREDIENTZ0H242BBR1ONDANSETRON TABLET, ORALLY DISINTEGRATING [DIRECT RX]2
CELLULOSE, MICROCRYSTALLINEINACTIVE INGREDIENTOP1R32D61UONDANSETRON TABLET, ORALLY DISINTEGRATING [PREFERRED PHARMACEUTICALS, INC.]2
CELLULOSE, MICROCRYSTALLINEINACTIVE INGREDIENTOP1R32D61UONDANSETRON TABLET, ORALLY DISINTEGRATING [RXCHANGE CO.]2
CROSPOVIDONEINACTIVE INGREDIENT68401960MKONDANSETRON TABLET, ORALLY DISINTEGRATING [DIRECT RX]2
CROSPOVIDONEINACTIVE INGREDIENT68401960MKONDANSETRON TABLET, ORALLY DISINTEGRATING [PREFERRED PHARMACEUTICALS, INC.]2
CROSPOVIDONEINACTIVE INGREDIENT68401960MKONDANSETRON TABLET, ORALLY DISINTEGRATING [RXCHANGE CO.]2
LACTOSE MONOHYDRATEINACTIVE INGREDIENTEWQ57Q8I5XONDANSETRON TABLET, ORALLY DISINTEGRATING [RXCHANGE CO.]2
LACTOSE MONOHYDRATEINACTIVE INGREDIENTEWQ57Q8I5XONDANSETRON TABLET, ORALLY DISINTEGRATING [PREFERRED PHARMACEUTICALS, INC.]2
LACTOSE MONOHYDRATEINACTIVE INGREDIENTEWQ57Q8I5XONDANSETRON TABLET, ORALLY DISINTEGRATING [DIRECT RX]2
MAGNESIUM STEARATEINACTIVE INGREDIENT70097M6I30ONDANSETRON TABLET, ORALLY DISINTEGRATING [PREFERRED PHARMACEUTICALS, INC.]2
MAGNESIUM STEARATEINACTIVE INGREDIENT70097M6I30ONDANSETRON TABLET, ORALLY DISINTEGRATING [DIRECT RX]2
MAGNESIUM STEARATEINACTIVE INGREDIENT70097M6I30ONDANSETRON TABLET, ORALLY DISINTEGRATING [RXCHANGE CO.]2
MANNITOLINACTIVE INGREDIENT3OWL53L36AONDANSETRON TABLET, ORALLY DISINTEGRATING [DIRECT RX]2
MANNITOLINACTIVE INGREDIENT3OWL53L36AONDANSETRON TABLET, ORALLY DISINTEGRATING [RXCHANGE CO.]2
MANNITOLINACTIVE INGREDIENT3OWL53L36AONDANSETRON TABLET, ORALLY DISINTEGRATING [PREFERRED PHARMACEUTICALS, INC.]2
SILICON DIOXIDEINACTIVE INGREDIENTETJ7Z6XBU4ONDANSETRON TABLET, ORALLY DISINTEGRATING [DIRECT RX]2
SILICON DIOXIDEINACTIVE INGREDIENTETJ7Z6XBU4ONDANSETRON TABLET, ORALLY DISINTEGRATING [RXCHANGE CO.]2
SILICON DIOXIDEINACTIVE INGREDIENTETJ7Z6XBU4ONDANSETRON TABLET, ORALLY DISINTEGRATING [PREFERRED PHARMACEUTICALS, INC.]2
ONDANSETRONACTIVE INGREDIENT4AF302ESOSONDANSETRON TABLET, ORALLY DISINTEGRATING [MEDSOURCE PHARMACEUTICALS]1
ONDANSETRONACTIVE INGREDIENT4AF302ESOSONDANSETRON TABLET, ORALLY DISINTEGRATING [PROFICIENT RX LP]1
ONDANSETRONACTIVE MOIETY4AF302ESOSONDANSETRON TABLET, ORALLY DISINTEGRATING [MEDSOURCE PHARMACEUTICALS]1
ONDANSETRONACTIVE MOIETY4AF302ESOSONDANSETRON TABLET, ORALLY DISINTEGRATING [PROFICIENT RX LP]1
ASPARTAMEINACTIVE INGREDIENTZ0H242BBR1ONDANSETRON TABLET, ORALLY DISINTEGRATING [MEDSOURCE PHARMACEUTICALS]1
ASPARTAMEINACTIVE INGREDIENTZ0H242BBR1ONDANSETRON TABLET, ORALLY DISINTEGRATING [PROFICIENT RX LP]1
CELLULOSE, MICROCRYSTALLINEINACTIVE INGREDIENTOP1R32D61UONDANSETRON TABLET, ORALLY DISINTEGRATING [MEDSOURCE PHARMACEUTICALS]1
CELLULOSE, MICROCRYSTALLINEINACTIVE INGREDIENTOP1R32D61UONDANSETRON TABLET, ORALLY DISINTEGRATING [PROFICIENT RX LP]1
CROSPOVIDONEINACTIVE INGREDIENT68401960MKONDANSETRON TABLET, ORALLY DISINTEGRATING [PROFICIENT RX LP]1
CROSPOVIDONEINACTIVE INGREDIENT68401960MKONDANSETRON TABLET, ORALLY DISINTEGRATING [MEDSOURCE PHARMACEUTICALS]1
LACTOSE MONOHYDRATEINACTIVE INGREDIENTEWQ57Q8I5XONDANSETRON TABLET, ORALLY DISINTEGRATING [PROFICIENT RX LP]1
LACTOSE MONOHYDRATEINACTIVE INGREDIENTEWQ57Q8I5XONDANSETRON TABLET, ORALLY DISINTEGRATING [MEDSOURCE PHARMACEUTICALS]1
MAGNESIUM STEARATEINACTIVE INGREDIENT70097M6I30ONDANSETRON TABLET, ORALLY DISINTEGRATING [PROFICIENT RX LP]1
MAGNESIUM STEARATEINACTIVE INGREDIENT70097M6I30ONDANSETRON TABLET, ORALLY DISINTEGRATING [MEDSOURCE PHARMACEUTICALS]1
MANNITOLINACTIVE INGREDIENT3OWL53L36AONDANSETRON TABLET, ORALLY DISINTEGRATING [PROFICIENT RX LP]1
MANNITOLINACTIVE INGREDIENT3OWL53L36AONDANSETRON TABLET, ORALLY DISINTEGRATING [MEDSOURCE PHARMACEUTICALS]1
SILICON DIOXIDEINACTIVE INGREDIENTETJ7Z6XBU4ONDANSETRON TABLET, ORALLY DISINTEGRATING [MEDSOURCE PHARMACEUTICALS]1
SILICON DIOXIDEINACTIVE INGREDIENTETJ7Z6XBU4ONDANSETRON TABLET, ORALLY DISINTEGRATING [PROFICIENT RX LP]1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
65862-391ONDANSETRON TABLET, ORALLY DISINTEGRATING [AUROBINDO PHARMA LIMITED]19Current NDC, Legacy NDC, 8 package rows20240418_cab63f24-8728-4927-aba5-53e8d2e44cdb.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 3 · 45 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
OndansetronONDANSETRONAsclemed USA, Inc.269c920c-643a-4eea-9bf9-b1f008915db92026-08-28Warnings, Adverse reactionsExact identifier
application applno (ANDA): 090469
application number: ANDA090469
OndansetronONDANSETRONPreferred Pharmaceuticals, Inc.66ac9c17-bea7-4f8d-8a27-a1e0f9e659452026-08-07Warnings, Adverse reactionsExact identifier
application applno (ANDA): 090469
application number: ANDA090469
OndansetronONDANSETRONPreferred Pharmaceuticals, Inc.70b48280-ef74-472b-abc3-128962bfcb052026-08-07Warnings, Adverse reactionsExact identifier
application applno (ANDA): 090469
application number: ANDA090469
OndansetronONDANSETRONSportpharm LLC3c4cda2f-13d9-42c5-b449-77deb06c8de52026-08-03Warnings, Adverse reactionsExact identifier
application applno (ANDA): 090469
application number: ANDA090469
OndansetronONDANSETRONHAWAII REPACK, INC.b76c5cc9-f1ca-428b-8989-36a66802b6502026-07-17Warnings, Adverse reactionsExact identifier
application applno (ANDA): 090469
application number: ANDA090469
OndansetronONDANSETRONREMEDYREPACK INC.18063a64-a4c0-4bad-911b-00df5c7bb65d2026-07-07Warnings, Adverse reactionsExact identifier
application applno (ANDA): 090469
application number: ANDA090469
OndansetronONDANSETRONBryant Ranch Prepack77397df5-5a4f-41b2-98bc-f817a1e497fc2026-07-02Warnings, Adverse reactionsExact identifier
application applno (ANDA): 090469
application number: ANDA090469
OndansetronONDANSETRONSportpharm LLC822404ad-af08-4c62-ae38-7d9819e860792026-07-01Warnings, Adverse reactionsExact identifier
application applno (ANDA): 090469
application number: ANDA090469
OndansetronONDANSETRONSt. Mary's Medical Park Pharmacy3207cf04-73b7-24ce-e054-00144ff8d46c2026-06-30Warnings, Adverse reactionsExact identifier
application applno (ANDA): 090469
application number: ANDA090469
ONDANSETRONONDANSETRONDirect Rxb38feff2-900a-4e0c-8260-8f090edbc0bc2026-03-17Warnings, Adverse reactionsExact identifier
application applno (ANDA): 090469
application number: ANDA090469
OndansetronONDANSETRONA-S Medication Solutions378d0963-d026-4478-8202-fbb636904a372026-02-18Warnings, Adverse reactionsExact identifier
application applno (ANDA): 090469
application number: ANDA090469
OndansetronONDANSETRONNuCare Pharmaceuticals,Inc.9dff6676-e69e-779d-e053-2995a90a7c812026-01-27Warnings, Adverse reactionsExact identifier
application applno (ANDA): 090469
application number: ANDA090469
OndansetronONDANSETRONNuCare Pharmaceuticals,Inc.76666e7e-3312-6f9d-e053-2991aa0af7052026-01-23Warnings, Adverse reactionsExact identifier
application applno (ANDA): 090469
application number: ANDA090469
OndansetronONDANSETRONNorthwind Health Company, LLCf2b502e2-03ed-fe5c-e053-2995a90a368e2026-01-01Warnings, Adverse reactionsExact identifier
application applno (ANDA): 090469
application number: ANDA090469
OndansetronONDANSETRONNorthwind Health Company, LLCdb9a0d22-9339-4319-e053-2a95a90a95922026-01-01Warnings, Adverse reactionsExact identifier
application applno (ANDA): 090469
application number: ANDA090469
OndansetronONDANSETRONNorthwind Health Company, LLCe07c38c0-e1c2-01de-e053-2995a90a390a2026-01-01Warnings, Adverse reactionsExact identifier
application applno (ANDA): 090469
application number: ANDA090469
OndansetronONDANSETRONPD-Rx Pharmaceuticals, Inc.9558d296-8edd-4aa1-875a-6247f9a8374d2025-09-15Warnings, Adverse reactionsExact identifier
application applno (ANDA): 090469
application number: ANDA090469
OndansetronONDANSETRONPD-Rx Pharmaceuticals, Inc.10afd68b-877f-4819-a314-39f2d56d5db92025-09-15Warnings, Adverse reactionsExact identifier
application applno (ANDA): 090469
application number: ANDA090469
OndansetronONDANSETRONPreferred Pharmaceuticals, Inc.b9abd5ce-6aca-4fda-8f46-0bb5b7fdd5da2025-09-04Warnings, Adverse reactionsExact identifier
application applno (ANDA): 090469
application number: ANDA090469
OndansetronONDANSETRONCardinal Health 107, LLCb50c1767-8a50-49ab-be31-6533021ae7c42025-08-21Warnings, Adverse reactionsExact identifier
application applno (ANDA): 090469
application number: ANDA090469

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
312087ondansetron 8 MG Disintegrating Oral TabletPSN2d1b8953-7ff5-4e91-ba97-3ba5c6ea8f71105
312087ondansetron 8 MG Disintegrating Oral TabletSCD2d1b8953-7ff5-4e91-ba97-3ba5c6ea8f71105
104894ondansetron 4 MG Disintegrating Oral TabletPSN378d0963-d026-4478-8202-fbb636904a3739
312087ondansetron 8 MG Disintegrating Oral TabletPSN378d0963-d026-4478-8202-fbb636904a3739
104894ondansetron 4 MG Disintegrating Oral TabletSCD378d0963-d026-4478-8202-fbb636904a3739
312087ondansetron 8 MG Disintegrating Oral TabletSCD378d0963-d026-4478-8202-fbb636904a3739
312087ondansetron 8 MG Disintegrating Oral TabletPSN10afd68b-877f-4819-a314-39f2d56d5db925
312087ondansetron 8 MG Disintegrating Oral TabletSCD10afd68b-877f-4819-a314-39f2d56d5db925
104894ondansetron 4 MG Disintegrating Oral TabletPSNcab63f24-8728-4927-aba5-53e8d2e44cdb20
312087ondansetron 8 MG Disintegrating Oral TabletPSNcab63f24-8728-4927-aba5-53e8d2e44cdb20
104894ondansetron 4 MG Disintegrating Oral TabletSCDcab63f24-8728-4927-aba5-53e8d2e44cdb20
312087ondansetron 8 MG Disintegrating Oral TabletSCDcab63f24-8728-4927-aba5-53e8d2e44cdb20
312087ondansetron 8 MG Disintegrating Oral TabletPSN18063a64-a4c0-4bad-911b-00df5c7bb65d13
312087ondansetron 8 MG Disintegrating Oral TabletSCD18063a64-a4c0-4bad-911b-00df5c7bb65d13
312087ondansetron 8 MG Disintegrating Oral TabletPSNb9abd5ce-6aca-4fda-8f46-0bb5b7fdd5da11
312087ondansetron 8 MG Disintegrating Oral TabletSCDb9abd5ce-6aca-4fda-8f46-0bb5b7fdd5da11
312087ondansetron 8 MG Disintegrating Oral TabletPSN3207cf04-73b7-24ce-e054-00144ff8d46c7
312087ondansetron 8 MG Disintegrating Oral TabletSCD3207cf04-73b7-24ce-e054-00144ff8d46c7
312087ondansetron 8 MG Disintegrating Oral TabletPSNf1191e52-982e-49d1-946e-01b469ccedfe6
312087ondansetron 8 MG Disintegrating Oral TabletPSNb38feff2-900a-4e0c-8260-8f090edbc0bc6
312087ondansetron 8 MG Disintegrating Oral TabletSCDb38feff2-900a-4e0c-8260-8f090edbc0bc6
312087ondansetron 8 MG Disintegrating Oral TabletSCDf1191e52-982e-49d1-946e-01b469ccedfe6
312087ondansetron 8 MG Disintegrating Oral TabletPSNf2b502e2-03ed-fe5c-e053-2995a90a368e5
312087ondansetron 8 MG Disintegrating Oral TabletPSN76666e7e-3312-6f9d-e053-2991aa0af7055
312087ondansetron 8 MG Disintegrating Oral TabletSCD76666e7e-3312-6f9d-e053-2991aa0af7055
312087ondansetron 8 MG Disintegrating Oral TabletSCDf2b502e2-03ed-fe5c-e053-2995a90a368e5
312087ondansetron 8 MG Disintegrating Oral TabletPSN9dff6676-e69e-779d-e053-2995a90a7c814
312087ondansetron 8 MG Disintegrating Oral TabletSCD9dff6676-e69e-779d-e053-2995a90a7c814
312087ondansetron 8 MG Disintegrating Oral TabletPSNc0640556-ae39-4b57-9030-03a23dcdb60c3
312087ondansetron 8 MG Disintegrating Oral TabletSCDc0640556-ae39-4b57-9030-03a23dcdb60c3
312087ondansetron 8 MG Disintegrating Oral TabletPSNb50c1767-8a50-49ab-be31-6533021ae7c42
312087ondansetron 8 MG Disintegrating Oral TabletPSN0e62c438-359f-4cec-a785-9c7ac09fa6f82
312087ondansetron 8 MG Disintegrating Oral TabletPSN1eb89f6e-6e01-5812-e054-00144ff88e882
312087ondansetron 8 MG Disintegrating Oral TabletSCDb50c1767-8a50-49ab-be31-6533021ae7c42
312087ondansetron 8 MG Disintegrating Oral TabletSCD1eb89f6e-6e01-5812-e054-00144ff88e882
312087ondansetron 8 MG Disintegrating Oral TabletSCD0e62c438-359f-4cec-a785-9c7ac09fa6f82
312087ondansetron 8 MG Disintegrating Oral TabletPSN238c260b-d7b8-e92a-e063-6394a90a666a1
312087ondansetron 8 MG Disintegrating Oral TabletSCD238c260b-d7b8-e92a-e063-6394a90a666a1

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
65862-391-01658620391011 BLISTER PACK in 1 CARTON (65862-391-01) / 10 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK1 blister pack2021-03-240000-00-00NoNoCurrent
65862-391-0265862039102100 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (65862-391-02) 2024-04-12NoNoCurrent
65862-391-0565862039105500 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (65862-391-05) 2024-04-12NoNoCurrent
65862-391-10658620391103 BLISTER PACK in 1 CARTON (65862-391-10) / 10 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK3 blister pack2010-04-120000-00-00NoNoCurrent
65862-391-306586203913030 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (65862-391-30) 2010-04-120000-00-00NoNoCurrent
65862-391-66658620391666000 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (65862-391-66) 2010-04-120000-00-00NoNoCurrent